IFF has launched Nurica enzyme in China, offering a new way for dairy producers to create a premium product to fulfill consumer health needs while increasing profitability. Nurica is IFF’s latest innovation for the Chinese market and is marketed under the Danisco range of food ingredients that are now part of the IFF family.

Consumers in China are increasingly looking for healthier offerings in their dairy products, including products with a higher fiber content to help achieve daily fiber intake and improve overall gut health and digestibility. 

According to IFF, using Nurica, dairy producers can adjust the sugar, fiber, and lactose content of their flavored milk, ice cream, and fermented dairy applications.

Gut health
Nurica is an innovative enzymatic solution that enables manufacturers to naturally produce dietary fibers in the form of GalactoOligoSaccharides (GOS) in situ by transforming lactose present in dairy products. 

GOS has also been shown to increase populations of health-promoting species of gut bacteria, and as such, has potential in prebiotic innovations and improving gut health.

In application trials, the Nurica lactase has shown no detectable impact on the acidification process, taste or texture. The outcome is stable, high-quality fermented dairy products, innovatively tailored to consumer health trends.

“NuricaTM allows producers to achieve at least 1.6 percent of GOS fiber generated in situ and create a lactose-free product that is easy to digest while reducing added sugar in the final product,” says Dr. Susan Jin, regional business leader, HMO’s, Probiotics, Cultures and Dairy Enzymes, Asia Pacific, IFF. 

“Unlike other lactases available on the market, Nurica can help dairy producers address multiple market trends such as high fiber, reduced sugar, and low or no lactose while maintaining quality and profitability.”